Treatment of Vaginal Candidiasis and Bacterial Vaginosis in Pregnancy
For vaginal candidiasis in pregnancy, use topical azole antifungals for 7 days (not oral fluconazole), and for bacterial vaginosis, treat symptomatic women with oral metronidazole 250 mg three times daily for 7 days or oral clindamycin 300 mg twice daily for 7 days—avoid clindamycin vaginal cream due to increased preterm delivery risk.
Vaginal Candidiasis in Pregnancy
Treatment Approach
Pregnant women with vulvovaginal candidiasis require topical azole therapy only—oral fluconazole should be avoided during pregnancy 1. The treatment duration must be extended compared to non-pregnant women.
Recommended topical regimens 1:
- Clotrimazole 1% cream: 5g intravaginally daily for 7-14 days
- Clotrimazole 2% cream: 5g intravaginally daily for 3 days (though longer courses preferred in pregnancy)
- Miconazole 2% cream: 5g intravaginally daily for 7 days
- Terconazole 0.4% cream: 5g intravaginally daily for 7 days
- Terconazole 0.8% cream: 5g intravaginally daily for 3 days
Key Clinical Points
The rationale for topical-only therapy stems from safety concerns—oral azoles cross the placental barrier, while topical agents achieve minimal systemic absorption 1. Recent evidence confirms that vaginal treatment alone is equally effective as combined vaginal plus oral treatment across all trimesters, with the added benefit of avoiding systemic fetal exposure 2.
Critical pitfall: Do not use single-dose or short-course (1-3 day) regimens in pregnancy. Pregnant women require 7-day courses minimum due to the estrogen-rich environment that promotes Candida growth 3.
Bacterial Vaginosis in Pregnancy
Risk Stratification Matters
The treatment approach differs based on preterm delivery risk:
High-risk women (prior preterm delivery):
- Screen at first prenatal visit
- Treat even if asymptomatic, as this may reduce preterm delivery 4
- Follow-up at 1 month post-treatment to confirm cure 5, 4
Low-risk women (no prior preterm delivery):
- Treat only if symptomatic 4
- Treatment primarily for symptom relief
Recommended Treatment Regimens
First-line systemic therapy 4:
- Metronidazole 250 mg orally three times daily for 7 days (preferred)
- Clindamycin 300 mg orally twice daily for 7 days (alternative)
Note the dosing difference: pregnant women receive lower doses (250 mg vs 500 mg metronidazole) to minimize fetal exposure 5.
Alternative for symptomatic low-risk women 5:
- Metronidazole 2g orally single dose
- Metronidazole gel 0.75%, one applicator intravaginally twice daily for 5 days
Critical Safety Warning
Do NOT use clindamycin vaginal cream in pregnancy 4. Three randomized trials demonstrated increased adverse events including prematurity and neonatal infections with intravaginal clindamycin 4. This is a crucial distinction—oral clindamycin is acceptable, but the vaginal formulation is contraindicated.
Evidence on Metronidazole Safety
Despite historical concerns about teratogenicity from animal studies, multiple meta-analyses have not demonstrated consistent associations between metronidazole use during pregnancy and teratogenic or mutagenic effects 4. The medication is considered safe, particularly when using the lower 250 mg dosing.
Treatment Timing
For high-risk women, screening and treatment should occur at the earliest part of the second trimester or at the first prenatal visit 5, 4. Earlier treatment in high-risk populations has shown benefit in reducing preterm delivery in 3 of 4 randomized controlled trials 4.
When Systemic Therapy is Preferred
Some experts recommend systemic (oral) therapy over topical agents for all pregnant women with BV to treat possible subclinical upper genital tract infections 4. The rationale: BV organisms are frequently present in postpartum endometritis and post-cesarean wound infections 4.
Partner Treatment
Do not treat sexual partners—this does not affect cure rates or recurrence 5, 4.
Common Clinical Pitfalls
- Using vaginal clindamycin cream (increases preterm delivery risk)
- Using standard non-pregnant doses (use 250 mg metronidazole, not 500 mg)
- Using oral fluconazole for candidiasis (topical only in pregnancy)
- Single-dose therapy for candidiasis (requires 7-day courses minimum)
- Failing to follow up high-risk BV patients (recheck at 1 month)